Samsung BioLogics Raises 30 Trillion Won via Equity Offering on August 28 to Fund Swiss PolyPeptide Acquisition
According to Yonhap Infomax citing FSC disclosures on August 28, Samsung BioLogics announced a 30 trillion won (approximately 23 billion USD) equity offering. The company will issue 2.27 million new shares, representing 4.9% of existing shares outstanding at 1.322 million won per share.
Samsung Biologics-2.78%
GateNews·08-27 23:16
